Tolerability and efficacy of ropinirole in patients with intermittent restless legs syndrome (RLS): Open-label results

被引：0

作者：

Black, J.

Merchant, K.

机构：

[1] GlaxoSmithKline Inc, Res Triangle Pk, NC USA

[2] Stanford Univ, Stanford, CA 94305 USA

来源：

MOVEMENT DISORDERS | 2006年 / 21卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1554 / 1554

页数：1

共 50 条

[31] Onset of symptom improvement after 2 nights in patients with restless legs syndrome (RLS) treated with ropinirole
Ziman, RB
Watson, CB
Bogan, RK
NEUROLOGY, 2006, 66 (05) : A82 - A82
[32] Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome
Schneider, Juliane
Krafft, Alexander
Manconi, Mauro
Huebner, Astrid
Baumann, Christian
Werth, Esther
Gyr, Thomas
Bassetti, Claudio
SLEEP MEDICINE, 2015, 16 (11) : 1342 - 1347
[33] Ropinirole is an effective treatment for restless legs syndrome (RLS) in patients who have failed other therapies
Ziman, RB
Earl, NL
Kushida, CA
Watson, CB
Giorgi, L
NEUROLOGY, 2006, 66 (05) : A81 - A82
[34] LONG-TERM TREATMENT WITH TRANSDERMAL ROTIGOTINE IN PATIENTS WITH IDIOPATHIC RESTLESS LEGS SYNDROME (RLS): RESULTS FROM A 12-MONTH OPEN-LABEL EXTENSION TRIAL
Allen, R. P.
Winkelman, J.
Ondo, W.
Fichtner, A.
Schollmayer, E.
SLEEP, 2010, 33 : A251 - A251
[35] Ropinirole is an effective treatment for restless legs syndrome (RLS) in patients who have failed other pharmacotherapies
Garcia-Borreguero, D.
Tidswell, P.
Earl, N. L.
EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 78 - 79
[36] Long-term open-label study of pramipexole in patients with primary restless legs syndrome
Inoue, Yuichi
Kuroda, Kenji
Hirata, Koichi
Uchimura, Naohisa
Kagimura, Tatsuo
Shimizu, Tetsuo
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 294 (1-2) : 62 - 66
[37] Gabapentin versus levodopa for the treatment of restless legs syndrome in hemodialysis patients: An open-label study
Micozkadioglu, H
Ozdemir, FN
Kut, A
Sezer, S
Saatci, U
Haberal, M
RENAL FAILURE, 2004, 26 (04) : 393 - 397
[38] Ropinirole improves objective motor symptoms of Restless Legs Syndrome (RLS) throughout the night
Becker, P. M.
Earl, N. L.
SLEEP, 2006, 29 : A276 - A277
[39] Tolerability with no loss of efficacy after overnight switch from immediate release (IR) ropinirole to a new extended-release formulation, ropinirole CR, in primary restless legs syndrome (RLS)
Lee, Daniel
Castiglia, Mary
NEUROLOGY, 2007, 68 (12) : A256 - A256
[40] Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score ≥ 24 points -: data from the ropinirole clinical trial programme
Giorgi, Luigi
Ritchie, Sally Y.
Kirsch, Jeffrey M.
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (10) : 1867 - 1877

← 1 2 3 4 5 →